Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
EYPT logo

EYPT

NSD
EyePoint Pharmaceuticals Inc.
HealthcareBiotechnology
Watchlists:
Last updated: Monday 14th July 2025
10.36
-0.70 (-6.33%)
Prev Close:11.06
Open:11.0
Bid:10.27
Ask:10.4
52 Week Range
3.91
13.99
Volume:777,685
Mkt Cap:685 M
Price Target
$11.91
+15.0%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

EYPT - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Invalid date
Depreciation And Amortization2 M500000.02 M311000.0189000.0
General And Administrative Expense52 M40 M35 M26 M21 M
Gross Profit Margin (profit Margin After CGS)43 M46 M33 M37 M34 M
Impairment Of Capital Assets21 M
Interest Expense Non Operating1 M3 M5 M7 M
Misc Other Special Charges15 M6 M572000.02 M-847000.0
Net Income (loss)-131 M-71 M-102 M-58 M-45 M
Net Income Common Stockholders-131 M-65 M-102 M-37 M-29 M
Net Income Continuous Operations-131 M-71 M-102 M-58 M-45 M
Net Non Operating Interest Income Expense-6 M1 M-5 M-7 M
Normalized Income-129 M-40 M
Operating Income-146 M-75 M-100 M-55 M-37 M
Operating Income Before Depreciation (EBITDA)-129 M-69 M-97 M-29 M-18 M
Operating Expense189 M121 M112 M92 M72 M
Other Gand A52 M40 M35 M26 M21 M
Other Operating Expenses3 M2 M-8 M-11 M-8 M
Research Expense133 M65 M50 M29 M17 M
Salaries And Wages37 M12 M
Selling And Marketing Expense131000.012 M26 M28 M25 M
Total Income Available For Interest Expense (EBIT)-131 M-69 M-99 M-32 M-22 M
Total Revenues43 M46 M41 M37 M34 M
Total Expenses189 M122 M120 M92 M72 M
Total Revenue43 M46 M41 M37 M34 M
Amord2 M3 M3 M
Avgshs56298.039 M37 M29 M13 M
Avgshsdt56298.039 M37 M29 M13 M
Basiceps-2.32-1.82-2.74-2.03-3.54
Basicepscont-2.32-1.82-2.74-2.03-3.54
Cor4 M500000.08 M
Depamor2 M500000.0400000.0311000.0189000.0
Dileps-2.32-1.82-2.74-2.03-3.54
Dilepscont-2.32-1.82-2.74
Netincdisc-131 M-71 M-102 M-58 M-45 M
Othincexp-15 M-6 M-22 M-2 M847000.0
Pretaxinc-131 M-71 M-102 M-37 M-29 M
Resdev133 M65 M50 M29 M17 M
Sga52 M52 M60 M53 M46 M
Shsout69 M50 M34 M34 M29 M
Specincchg-21 M
Taxprov90000.083000.0-6 M-3 M-3 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader